B0F logo

Paxman DB:B0F Stock Report

Last Price

€7.08

Market Cap

€149.2m

7D

7.3%

1Y

125.5%

Updated

08 May, 2025

Data

Company Financials +

B0F Stock Overview

Develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. More details

B0F fundamental analysis
Snowflake Score
Valuation3/6
Future Growth6/6
Past Performance6/6
Financial Health6/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Paxman AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Paxman
Historical stock prices
Current Share PriceSEK 7.08
52 Week HighSEK 7.26
52 Week LowSEK 3.14
Beta0.37
1 Month Change23.78%
3 Month Change14.94%
1 Year Change125.48%
3 Year Change37.74%
5 Year Changen/a
Change since IPO41.18%

Recent News & Updates

Recent updates

Shareholder Returns

B0FDE Medical EquipmentDE Market
7D7.3%-1.7%1.7%
1Y125.5%-12.3%12.8%

Return vs Industry: B0F exceeded the German Medical Equipment industry which returned -12.3% over the past year.

Return vs Market: B0F exceeded the German Market which returned 12.8% over the past year.

Price Volatility

Is B0F's price volatile compared to industry and market?
B0F volatility
B0F Average Weekly Movement9.5%
Medical Equipment Industry Average Movement5.7%
Market Average Movement6.3%
10% most volatile stocks in DE Market13.0%
10% least volatile stocks in DE Market3.1%

Stable Share Price: B0F's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: B0F's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
1996105Richard Paxmanpaxmanscalpcooling.com

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to utilize state-of-the-art technological advances to develop a wearable medical cooling device, and the National University Hospital of Singapore for the development of a cooling and compression system.

Paxman AB (publ) Fundamentals Summary

How do Paxman's earnings and revenue compare to its market cap?
B0F fundamental statistics
Market cap€149.24m
Earnings (TTM)€3.68m
Revenue (TTM)€24.08m

40.6x

P/E Ratio

6.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
B0F income statement (TTM)
RevenueSEK 263.20m
Cost of RevenueSEK 87.78m
Gross ProfitSEK 175.42m
Other ExpensesSEK 135.22m
EarningsSEK 40.20m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

May 16, 2025

Earnings per share (EPS)1.92
Gross Margin66.65%
Net Profit Margin15.27%
Debt/Equity Ratio8.7%

How did B0F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/08 00:36
End of Day Share Price 2025/05/08 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Paxman AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mats HyttingeRedeye